Q4 2012
Released Mar 28, 2013, after the close
10-K filed Mar 28, 2013, 87 days after period end · 0001193125-13-132600
Q4 2012 · 10-K
Revenue$34.00K$34.00K no prior Q4 2011 on file−59.5% vs Q3 2012
Net Income-$2.43M-$2.43M N/M vs Q4 2011N/M vs Q3 2012
EPS Diluted-$0.14-$0.14 N/M vs Q4 2011N/M vs Q3 2012
Operating Incomederived-$2,421,182N/M
Operating Cash Flowderived-$2,186,630—
Free Cash Flowderived-$2,186,832—
Margins · derived
Operating margin-7121.1%
Net margin-7158.8%
What the release said
The release
Same quarter
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $34.00K | — | — |
| Net Income | -$2.43M | -$3.50M | — |
| EPS Diluted | -$0.14 | -$0.22 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR